AU2003229667A1 - Antigen-loaded chitosan microparticles for oral vaccination - Google Patents
Antigen-loaded chitosan microparticles for oral vaccinationInfo
- Publication number
- AU2003229667A1 AU2003229667A1 AU2003229667A AU2003229667A AU2003229667A1 AU 2003229667 A1 AU2003229667 A1 AU 2003229667A1 AU 2003229667 A AU2003229667 A AU 2003229667A AU 2003229667 A AU2003229667 A AU 2003229667A AU 2003229667 A1 AU2003229667 A1 AU 2003229667A1
- Authority
- AU
- Australia
- Prior art keywords
- antigen
- oral vaccination
- loaded chitosan
- chitosan microparticles
- microparticles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/00088—Details for redistribution
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02076508 | 2002-04-18 | ||
EP02076508.7 | 2002-04-18 | ||
PCT/EP2003/003875 WO2003086454A1 (en) | 2002-04-18 | 2003-04-14 | Antigen-loaded chitosan microparticles for oral vaccination |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003229667A1 true AU2003229667A1 (en) | 2003-10-27 |
Family
ID=29225678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003229667A Abandoned AU2003229667A1 (en) | 2002-04-18 | 2003-04-14 | Antigen-loaded chitosan microparticles for oral vaccination |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003229667A1 (en) |
WO (1) | WO2003086454A1 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2457027C (en) | 2001-08-16 | 2011-10-11 | Medical Research Council | Chitin microparticles and their medical uses |
US7959929B2 (en) | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
US11865172B2 (en) | 2005-04-21 | 2024-01-09 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
ES2470340T3 (en) | 2005-12-28 | 2014-06-23 | Advanced Bionutrition Corporation | Administration vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in vitreous form |
CA2643322C (en) * | 2006-02-24 | 2015-07-21 | Novartis Ag | Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions |
NO2105129T3 (en) | 2008-03-24 | 2018-06-16 | ||
US8778384B2 (en) | 2008-03-24 | 2014-07-15 | Advanced Bionutrition Corporation | Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals |
ES2908047T3 (en) | 2009-03-27 | 2022-04-27 | Intervet Int Bv | Microparticle vaccines for oral or nasal vaccination and boosting of animals including fish |
NZ597053A (en) | 2009-05-26 | 2014-02-28 | Advanced Bionutrition Corp | Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making |
EP2529004B1 (en) | 2010-01-28 | 2017-06-07 | Advanced Bionutrition Corporation | Dry glassy composition comprising a bioactive material |
US9504750B2 (en) | 2010-01-28 | 2016-11-29 | Advanced Bionutrition Corporation | Stabilizing composition for biological materials |
CN103140145B (en) | 2010-08-13 | 2014-08-20 | 高级生物营养公司 | Dry storage stabilizing composition for biological materials |
CN104755092A (en) * | 2012-10-30 | 2015-07-01 | 雀巢产品技术援助有限公司 | Compositions comprising microparticles and probiotics to deliver a synergistic immune effect |
CN103777018A (en) * | 2014-01-16 | 2014-05-07 | 江西农业大学 | Preparation method of test strip for rapidly diagnosing porcine contagious pleuropneumonia actinobacillus |
CA2994112C (en) | 2015-07-29 | 2023-08-08 | Advanced Bionutrition Corp. | Stable dry probiotic compositions for special dietary uses |
CN107661416A (en) * | 2017-06-25 | 2018-02-06 | 西北农林科技大学 | A kind of traditional Chinese medicine extraction compound pharmaceutical for preventing and treating livestock and birds respiratory disease |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9522351D0 (en) * | 1995-11-01 | 1996-01-03 | Medeva Holdings Bv | Vaccine compositions |
-
2003
- 2003-04-14 AU AU2003229667A patent/AU2003229667A1/en not_active Abandoned
- 2003-04-14 WO PCT/EP2003/003875 patent/WO2003086454A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003086454A1 (en) | 2003-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003225444A1 (en) | Oral suspension formulation | |
AU2003221497A1 (en) | Pharmaceutical microparticles | |
AU2003232330A1 (en) | Method of preparing microparticles | |
AU2002353378A1 (en) | Vaccine for periodontal disease | |
AU2003299535A1 (en) | Group b streptococcus vaccine | |
AU2003294536A1 (en) | Dental handpiece | |
AU2003238812A1 (en) | Dental implant | |
AU2003229667A1 (en) | Antigen-loaded chitosan microparticles for oral vaccination | |
AU2003202818A1 (en) | A dental implant system | |
AU2002367771A1 (en) | Orthodontic separators | |
EP1398061A3 (en) | Oral appliance suitable for use as mouth guard | |
AU2002242935A1 (en) | A process for the preparation of a non-toxic anthrax vaccine | |
AU2003290436A1 (en) | Oral preparation system | |
AU2003285320A1 (en) | Vaccine | |
AU2003212776A1 (en) | Microparticles | |
AU2003293390A1 (en) | Improved dental bur | |
AU2003289603A1 (en) | Tumor vaccine | |
AU2003215187A1 (en) | Dental device | |
AU2003243038A1 (en) | Orthodontic implant | |
AU2003205169A1 (en) | Viral vaccine production method | |
AU2003262383A1 (en) | Process for preparing gabapentin | |
AU2003249282A1 (en) | Glanders/meliodosis vaccines | |
GB0201382D0 (en) | Virus-like particles | |
AU2003245469A1 (en) | Dental whitening | |
AU2003273035A1 (en) | Gene vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |